RBC maintains Connetics at outperform

Connetics Corp. was maintained at its outperform rating, speculative risk, and $10 price target by RBC Capital Markets analyst Ken Trbovich as 2008 noteholders agree to modified covenants due to incentives, and the company announced restatement of about $11 million. The analyst believes the most likely scenario is that the company pays the 2015 noteholders $200 million and makes $4.5 million in payments to 2008 holder for their consent to the waiver. This scenario, although dilutive, removes uncertainty and avoids a potential cash-crunch which would result from having to pay both notes at par. Shares of the Palo Alto, Calif.-based specialty pharmaceutical company were up 20 cents, or 2.44%, at $8.41 on volume of 712,160 shares versus the three-month running average of 779,323 shares. (Nasdaq: CNCT)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.